cisatracurium + sufentanil

Cisatracurium + sufentanil is a combination of two intravenous drugs commonly used in anesthesia. Cisatracurium is a non-depolarizing neuromuscular blocking agent of intermediate duration, used to induce skeletal muscle relaxation during surgery or mechanical ventilation by competitively antagonizing acetylcholine at nicotinic cholinergic receptors on the motor end-plate, resulting in paralysis of skeletal muscles[4][6][7]. Sufentanil is a potent synthetic opioid analgesic that acts primarily as an agonist at the mu-opioid receptor, providing profound analgesia and sedation; it is used as an adjunct to general anesthesia and for the management of severe acute pain[2][5]. The combination facilitates tracheal intubation, provides muscle relaxation for surgical procedures, and ensures adequate analgesia during operations requiring deep anesthesia. Both agents are administered intravenously under close medical supervision.

Brand names

Dzuveo

Other names

cisatracurium besylatecisatracurium besilate51W89